Market Overview:
The global regenerative therapies for osteoarthritis market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing prevalence of osteoarthritis, rising awareness about regenerative therapies, and technological advancements in the field of regenerative therapies. The global regenerative therapies for osteoarthritis market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into cell therapy, tissue engineering, and gene therapy. Cell therapy dominates the global regenerative therapies for osteoarthritis market owing to its ability to regenerate damaged tissues. On the basis of application, hospitals account for a major share in terms of revenue in this market due to increased adoption rates across developed countries. However, ambulatory surgical centers are expected to witness higher growth rates duringthe forecast period owingto their lower costs and shorter treatment times as compared with hospitals.
Product Definition:
Regenerative therapies for osteoarthritis are treatments that can help to regenerate the cartilage in joints that have been damaged by osteoarthritis. These therapies can include injections of stem cells or other growth factors, or surgery to transplant cartilage from another part of the body into the joint. Regenerative therapies for osteoarthritis are important because they can help to restore function and mobility to joints that have been damaged by this condition.
Cell Therapy:
Cell therapy is a regenerative medical practice that involves the use of living cells and their therapeutic properties for treating disease processes. The most common diseases treated using cell therapies include cancer, HIV infection, Leukemia, Autoimmune Disease ( Lupus etc.), cardiovascular diseases ( Myocardial Infarction), respiratory disorders and diabetes mellitus.
Tissue Engineering:
Osteoarthritis (OA) is a chronic degenerative disease of the knee and hip joints, which affects around 20% of the population worldwide. The disease progression leads to loss of cartilage in these joints, thereby increasing pain and limiting mobility. OA has no permanent cure at present; however, research is being undertaken for developing regenerative therapies that can be used to replace or restore lost joint cartilage.
Application Insights:
The research institutes application segment held the largest share of over 70.0% in 2017. This is attributed to the rising number of R&D initiatives for regenerative therapies for osteoarthritis at various research institutes and hospitals across the world. For instance, The University of Texas Medical Branch at Galveston has been working on tissue engineering techniques to develop a cure for osteoarthritis by growing new cartilage cells from human stromal cells using an artificial environment known as 3-dimensional (3D) culture system.
Regenerative therapies are gaining immense popularity among patients owing to their ability to restore joint health and mobility despite advanced age or disease state, which was not possible with conventional treatments such as surgery or medication.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of osteoarthritis and related disorders. According to statistics published by Arthritis Care & Research, Inc., around 30 million adults were diagnosed with arthritis in the U.S. alone in 2015, with over 11 million people suffering from moderate or severe forms of the disease affecting their hips or knees most commonly.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to an increase in healthcare expenditure and awareness regarding these therapies among patients and physicians alike.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for regenerative therapies for osteoarthritis.
- Rising awareness about regenerative therapies: There is a growing awareness about the benefits of regenerative therapies and this is likely to boost the market growth in the coming years.
- Technological advancements: The technological advancements in regenerative therapies are providing new treatment options for patients suffering from osteoarthritis, thereby propelling the market growth.
- Growing number of clinical studies on regenerative therapies: There has been an increase in number of clinical studies on various types of regenerative therapies, which is aiding in better understanding of these treatments and their potential applications in treating osteoarthritis patients. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Regenerative Therapies for Osteoarthritis Market Research Report
By Type
Cell Therapy, Tissue Engineering, Gene Therapy
By Application
Hospitals, Ambulatory Surgical Centers, Orthopaedic Clinics, Research Institutes
By Companies
Acelity, Mesoblast, Nuo Therapeutics, Astellas Pharma, Organovo, Orgenesis, Sanofi, Athersys, Takeda, Cytori Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global Regenerative Therapies for Osteoarthritis Market Report Segments:
The global Regenerative Therapies for Osteoarthritis market is segmented on the basis of:
Types
Cell Therapy, Tissue Engineering, Gene Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Orthopaedic Clinics, Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Acelity
- Mesoblast
- Nuo Therapeutics
- Astellas Pharma
- Organovo
- Orgenesis
- Sanofi
- Athersys
- Takeda
- Cytori Therapeutics
Highlights of The Regenerative Therapies for Osteoarthritis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell Therapy
- Tissue Engineering
- Gene Therapy
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Orthopaedic Clinics
- Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Regenerative Therapies for Osteoarthritis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Regenerative therapies are treatments that help to regenerate damaged cells and tissues. These therapies can be used to treat a variety of conditions, including osteoarthritis.
Some of the key players operating in the regenerative therapies for osteoarthritis market are Acelity, Mesoblast, Nuo Therapeutics, Astellas Pharma, Organovo, Orgenesis, Sanofi, Athersys, Takeda, Cytori Therapeutics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Regenerative Therapies for Osteoarthritis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Regenerative Therapies for Osteoarthritis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Regenerative Therapies for Osteoarthritis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Regenerative Therapies for Osteoarthritis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Regenerative Therapies for Osteoarthritis Market Size & Forecast, 2020-2028
4.5.1 Regenerative Therapies for Osteoarthritis Market Size and Y-o-Y Growth
4.5.2 Regenerative Therapies for Osteoarthritis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cell Therapy
5.2.2 Tissue Engineering
5.2.3 Gene Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Orthopaedic Clinics
6.2.4 Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Regenerative Therapies for Osteoarthritis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Regenerative Therapies for Osteoarthritis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cell Therapy
9.6.2 Tissue Engineering
9.6.3 Gene Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Orthopaedic Clinics
9.10.4 Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cell Therapy
10.6.2 Tissue Engineering
10.6.3 Gene Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Orthopaedic Clinics
10.10.4 Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cell Therapy
11.6.2 Tissue Engineering
11.6.3 Gene Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Orthopaedic Clinics
11.10.4 Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cell Therapy
12.6.2 Tissue Engineering
12.6.3 Gene Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Orthopaedic Clinics
12.10.4 Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cell Therapy
13.6.2 Tissue Engineering
13.6.3 Gene Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Orthopaedic Clinics
13.10.4 Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Regenerative Therapies for Osteoarthritis Market: Competitive Dashboard
14.2 Global Regenerative Therapies for Osteoarthritis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Acelity
14.3.2 Mesoblast
14.3.3 Nuo Therapeutics
14.3.4 Astellas Pharma
14.3.5 Organovo
14.3.6 Orgenesis
14.3.7 Sanofi
14.3.8 Athersys
14.3.9 Takeda
14.3.10 Cytori Therapeutics
